stockmarketproxy
/
DGXNYSE SEC EDGAR

QUEST DIAGNOSTICS INC

Services-Medical Laboratories·SECAUCUS, NJ·FY end 12/31·CIK 1022079
OverviewFinancialsCompensationGovernanceInsidersFilings

Financials

5-year history · USD
MetricFY 2025FY 2024FY 2023FY 2022FY 2021Trend
Revenue$11.0B$9.9B$9.3B$9.9B$10.8B
Gross Profit——————
Operating Income$1.6B$1.3B$1.3B$1.4B$2.4B
Net Income$992.0M$871.0M$854.0M$946.0M$2.0B
Operating CF$1.9B$1.3B$1.3B$1.7B$2.2B
Capex$527.0M$425.0M$408.0M$404.0M$403.0M
Free Cash Flow$1.4B$909.0M$864.0M$1.3B$1.8B
Buybacks$450.0M$151.0M$275.0M$1.4B$2.2B
Dividends$353.0M$331.0M$314.0M$305.0M$309.0M
Gross Margin——————
Operating Margin14.1%13.6%13.6%14.4%22.1%
Net Margin9.0%8.8%9.2%9.6%18.5%
FCF Margin12.3%9.2%9.3%13.3%17.0%
R&D / Revenue——————
Effective Tax——————
Debt / Equity1.511.751.451.351.24
Buybacks / FCF33.1%16.6%31.8%107.2%120.2%

Peer comparison

Services-Medical Laboratories · 3 peers
CEO Pay Ratio
DGX
275:1
NTRA
101:1
LH
292:1
GH
44:1
CEO total comp
DGX
$15M
NTRA
$15M
LH
—
GH
—
Net Margin
DGX
9.0%
NTRA
-9.0%
LH
6.3%
GH
-42.4%